Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (34)	3/22/2001 10:09:56 PM
From: rkrw	Read Replies (1) \| Respond to of 411

Wilder, Good question. Current angina meds are not clean. Looking at side effects for antiangina meds and ran: Nitrates: 42% headaches, 9% dizziness Diltiazem: 10% headache, 20% edema, 4% dizziness, 6% fatigue, 3% nausea. Atenolol: 13% dizziness, 32% fatigue, 12% depression, 12% cold extremities, 3% nausea. Ranolazine (High dose being tested 1000mg): 5% dizziness, 2% asthenia, 2% nausea. I took the numbers from a brokerage report, so you may want to verify :-) The key advantage cv is counting on is reduced side effects and no effect on heart rate or blood pressure. All the current meds work by reducing the heart work load via reducing heart rate, blood pressure or pumping force.